Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756725 | SCV000884617 | likely pathogenic | Autosomal recessive nonsyndromic hearing loss 16 | 2018-09-28 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV001169910 | SCV001251857 | pathogenic | not provided | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000756725 | SCV002763099 | likely pathogenic | Autosomal recessive nonsyndromic hearing loss 16 | criteria provided, single submitter | clinical testing | ||
Prevention |
RCV003424328 | SCV004117508 | likely pathogenic | STRC-related condition | 2023-05-19 | criteria provided, single submitter | clinical testing | The STRC c.3460C>T variant is predicted to result in premature protein termination (p.Arg1154*). To our knowledge, this variant has not been reported in the literature in patient's with STRC-related disease. This variant is reported in 0.15% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-43902548-G-A). Nonsense variants in STRC are expected to be pathogenic. This variant is interpreted as likely pathogenic. |